TLDR Stopping aripiprazole can reverse its side effect of hair loss.
The document reports a case of hair loss attributed to the use of aripiprazole, an atypical antipsychotic drug with antidepressant effects that acts on dopamine D2 and serotonin 5-HT1A receptors. Aripiprazole is prescribed for various psychiatric disorders such as schizophrenia, bipolar disorders, major depressive disorder, and anxiety disorders. The hair loss observed in the patient was a diffuse, non-scarring type and was reversible upon cessation of the medication. The case suggests that hair loss might be a class effect of psychotropic medications, although further research is necessary to understand the precise mechanisms behind hair loss induced by these drugs.
9 citations
,
October 2012 in “Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology” Stopping the drug olanzapine can reverse hair loss caused by it.
129 citations
,
October 2007 in “The New England Journal of Medicine” Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.
19 citations
,
February 2007 in “International Clinical Psychopharmacology” Quetiapine may cause hair loss, a side effect not widely recognized before.
August 2025 in “The Journal of Sexual Medicine” Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.
1 citations
,
December 2014 in “Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology” Adding aripiprazole to the treatment improved hair-pulling symptoms in a teenager.
March 2017 in “Fundamental & Clinical Pharmacology” The model and estimator can predict drug exposure in kidney transplant patients well.
December 2006 in “The Brown University Psychopharmacology Update” Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.
6 citations
,
October 2013 in “Expert Review of Dermatology” Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.
